This site uses cookies to improve your browsing experience. By continuing to browse this site you are agreeing to our use of cookies. For further information, please refer to
Privacy Policy
.
×
Ever Supreme Bio Technology
Language
繁中
EN
About Us
History
Founder and Company Mission
Pharmaceutical companies and awards
Management Team
Pharma Business
Core Technologies
Immune Cell Technology Platform
Stem Cell Technology Platform
Nanoparticle Pharmaceutical Platform
Exosome Technology Platform
Product Development
New drug development
Regeneration technology
News Center
News
ESG
Links
Government Agencies
Academic Institutions
Lndustry Lnsights
ESG
Corporate Governance
Structure
Board of Directors
Audit Committee
Remuneration Committee
Functional Committee
Major Internal Policies
Important information related to corporate governance
相關管理辦法
其他相關資訊
Sustainability
Sustainable Governance
Environment Mangement
DEI
Social Relationships
Downloads
113年
112年
Investor Zone
Material Information
Financial Information
Financial Reports
2025
2024
2023
2022
Shareholder's Services
Major Shareholders
Shareholders’ Meeting
114年
Dividends
Downloads
Annual Report
Investor Conferences
Investor Conferences
Stakeholder Engagement
Public Information Observation Station
Recruitment
Recruitment Information
Contact Us
Disclaimer
Terms
Privacy
News Center:Media reports
Home
News Center
Media reports
News
ESG
Links
2026.01.21
[Ever-Supreme and China University of Ch...
This year, Ever-Supreme once again partnered with China University of Chinese Medicine to ...
[Ever-Supreme and China University of Chinese Medicine Hospital Join Hands for Continuous Love Delivery]
2025.12.22
Interview with Founder Mr. Chang-Hai Tsa...
Under the leadership of its founder, Mr. Chang-Hai Tsai, Ever-Supreme (6712) continues to ...
Interview with Founder Mr. Chang-Hai Tsai
2025.12.20
Ever-Supreme participated in the 2025 Ta...
The 2025 Annual Meeting of the Taiwan Society of Neurosurgery (TSNS) and the 17th First Ge...
Ever-Supreme participated in the 2025 Taiwan Neurosurgical Society Annual Meeting and the 17th First General Meeting
2025.12.20
Ever-Supreme held a movie screening even...
Ever-Supreme held a movie screening event on December 20th to give back to its employees. ...
Ever-Supreme held a movie screening event on December 20th to give back to its employees, enhancing emotional connections and interaction among them, and allowing them to spend a warm time with family and friends, which can positively impact their work.
2025.11.28
Ever-Supreme won the "2025 Modena Taiwan...
On November 28th, the Biomedical Translational Research Center (BioTReC) of Academia Sinic...
Ever-Supreme won the "2025 Modena Taiwan mRNA Foresight Innovation Award", receiving unanimous recognition from the judges.
2025.11.25
Taipei Veterans General Hospital receive...
Taipei Veterans General Hospital, one of the medical institutions cooperating with Ever-Su...
Taipei Veterans General Hospital received approval from the Ministry of Health and Welfare on November 25, 2025, for its "Autologous Immune Cell (gamma-delta T)" cell therapy project to treat "Stage IV Solid Cancer".
2025.11.18
Ever-Supreme was awarded the "2025 Natio...
On November 18th, the Ministry of Health and Welfare and the Ministry of Economic Affairs ...
Ever-Supreme was awarded the "2025 National Drug Science and Technology Research and Development Award - Pharmaceutical Category - Bronze Award," and its outstanding achievements in the research and development field were unanimously recognized by the jud
2025.10.29
The "1000 Girls, 1000 Dreams" event, joi...
Ever-Supreme, China Medical University Hospital, and World Vision Taiwan jointly held a pr...
The "1000 Girls, 1000 Dreams" event, jointly organized by Ever-Supreme, China Medical University Hospital, and World Vision Taiwan, on October 15th, responded to the belief that "change begins with understanding," continuing to spread love an
1
2
3
1
2
3
TOP
About Us
History
Founder and Company Mission
Pharmaceutical companies and awards
Management Team
Pharma Business
Core Technologies
Immune Cell Technology Platform
Stem Cell Technology Platform
Nanoparticle Pharmaceutical Platform
Exosome Technology Platform
Product Development
New drug development
Regeneration technology
News Center
News
ESG
Links
Government Agencies
Academic Institutions
Lndustry Lnsights
ESG
Corporate Governance
Structure
Board of Directors
Audit Committee
Remuneration Committee
Functional Committee
Major Internal Policies
Important information related to corporate governance
相關管理辦法
其他相關資訊
Sustainability
Sustainable Governance
Environment Mangement
DEI
Social Relationships
Downloads
113年
112年
Investor Zone
Material Information
Financial Information
Financial Reports
2025
2024
2023
2022
Shareholder's Services
Major Shareholders
Shareholders’ Meeting
114年
Dividends
Downloads
Annual Report
Investor Conferences
Investor Conferences
Stakeholder Engagement
Public Information Observation Station
Recruitment
Recruitment Information
Contact Us
Disclaimer
Terms
Privacy
Language
繁中
EN